Pharmacopées, ouvrages relatifs à la pharmacie et aux médicaments

<p>Wertheimer, Albert<br><br>Scheduled closure of pharmpress.com<br><br>Edited by Albert Wertheimer, Temple University School of Pharmacy, Philadelphia, USA<br><br>ISSN 1759-8885<br><br>Paperback 275 x 210mm<br><br><br>DESCRIPTION:<br><br> The Royal Pharmaceutical Society's learned journals are published by Oxford University Press on behalf of the Society. <br> Journal of Pharmaceutical Health Services Research aims to become a focal point for the publication of all aspects of research within the field of health services research that relate to pharmaceuticals. <br>Health services research (HSR) can be defined as the multidisciplinary field of scientific investigation that studies how social factors, financing systems, organizational structures and processes, health technologies, and personal behaviours affect access to health care, the quality and cost of health care, and quantity and quality of life. Studies in health services research examine outcomes at the individual, family, organizational, institutional, community, and population level. HSR studies examine how people get access to health care, how much care costs, and what happens to patients as a result of this care. The primary goals of HSR are to identify the most effective ways to organize, manage, finance, and deliver high quality care, reduce medical errors and improve patient safety. <br>Pharmaceutical health services research incorporates pharmacoeconomics, health economics, finance, health outcomes, health planning and policy analysis, technology assessment and pharmacoepidemiology. The Journal welcomes papers on cost-benefit and cost-effectiveness studies, and the financial implications and political outcomes of drug policy. <br> <br> </p>

<p>Kayne, Steven B<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Edited by Steven B Kayne - Honorary Consultant Pharmacist, Glasgow Homeopathic Hospital; Honorary Lecturer, University of Strathclyde School of Pharmacy, Glasgow, UK<br><br>ISBN 978 0 85369 833 3<br><br>Published Nov 2009<br><br>Paperback 234 x 156mm (352pp)<br><br><br>DESCRIPTION:<br><br>The World Health Organization has acknowledged that the majority of people living in developing countries continue to use traditional medicine. Increased levels of immigration and migration also mean that health professionals are more likely to come into contact with patients using them. <br>Traditional Medicine is therefore a vital and timely book which covers medical systems practised on five continents, including: <br> - traditional European folk medicine <br> - Aboriginal/traditional medicine in North America <br> - traditional medicine in the Colombian Amazon Tropical forest <br> - traditional medical practice in Africa <br> - traditional Chinese medicine <br> - Indian Ayurvedic medicine <br> - Japanese Kampo medicine <br> - Korean medicine <br> - traditional medicines in the Pacific <br> - traditional Jewish medicine<br>Each section, written by an acknowledged expert, gives information on history, philosophy, methods of practice, safety issues, evidence, and examples of medicines.<br>Traditional Medicine is a crucial resource for complementary and alternative practitioners and students worldwide. It enables healthcare providers working in a multicultural society to interact effectively with their patients. Traditional Medicine is also available as an eBook.<br> <br>CONTENTS:<br><br> 1. Introduction to Traditional Medicine<br> 2. European Folk Medicine<br> 3. Native North American Medicine<br> 4. South American Medicine<br> 5. Africa<br> 6. Chinese and Tibetan Medicine<br> 7. Indian Ayurveda and Ulana<br> 8. Japanese Kampo Medicine<br> 9. Korean Medicine<br> 10. Pacific<br> 11. Biblical Medicine<br> </p>

<p>Braverman, Jordan<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Jordan Braverman, US Consultant in Health Economics<br><br>ISBN 978 0 85369 867 8<br><br>Published Nov 2009<br><br>Paperback 234 x 156mm (384pp)<br><br><br>DESCRIPTION:<br><br> Health Economics is an introductory discourse of health care in America today designed to acquaint students with a practical analysis of the prominent economic issues. <br>It considers health care in terms of cost, affordability and historical development and assesses contributing factors to the economic health crisis, including medical technology, prescription drugs and hospital care. Addressing the magnitude of the economic crisis, as well as physician and nursing home care and managed care, coverage also includes: <br> - home and hospice care <br> - health care planning <br> - private health insurance <br> - medicaid and medicare <br> - health care fraud and abuse <br> - national health insurance. <br>The economics of each field are discussed in detail, with all their socio-economic and political ramifications both within and outside the health care system. <br>This insightful and timely book will be an invaluable resource for students of any health care discipline, practicing health care physicians, economists, sociologists and health care researchers wishing to know more about the current health care crisis in the USA and what mechanisms exist to counter it.<br> Health Economics is also available as an eBook . <br> <br>CONTENTS:<br><br> 1. History of Health Care Financing in America <br> 2. The Costs of American Health Care<br> 3. The High Costs of Health Care: The Reasons Why <br> 4. Physician Care<br> 5. Prescription Drugs <br> 6. Hospital Care<br> 7. Medical Technology <br> 8. Nursing Home Care <br> 9. Home Care and Hospice Care <br> 10. Health Care Planning<br> 11. Private Health Insurance <br> 12. Managed Care<br> 13. Medicaid and Medicare <br> 14. Health Care Fraud and Abuse <br> 15. National Health Insurance<br> <br>REVIEWS:<br><br> 01-Jul-2011, Chromatographia <br>"Apocalytpic, ticking time bomb, on the brink and crisis waiting to happen - this is the key take-home message emanating from this informative and interesting overview of the US healthcare system. The stated objective of the book is to provide an introductory analysis to acquaint students with the economic issues confronting US healthcare...This is a solid, well-written and comprehensive book with every chapter authoritative and informative." <br> S. Carroll, Berkshire, UK, Chromatographia, July 2011. <br> </p>

<p>The BP 2023 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2023<br>Available from 1 August 2022 | Effective from 1 January 2023 | Superseding the BP 2022.<br><br>The British Pharmacopoeia (BP) 2021 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines &amp; HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia and BP Veterinary texts being included, the new BP 2023 edition also features:<br><br>Monographs and BPCRS:<br><br>23 new BP monographs, 59 new Ph. Eur. monographs.<br>151 amended BP monographs.<br>All monographs from the Ph. Eur. 10th edition as amended by supplements 10.1 to 10.8 are included.<br>The Ph. Eur. 11th edition, as amended by supplements 11.1 and 11.2 are included as in-year online and download product updates.<br>Updates to BPCRS coincide with BP 2023 to ensure that you remain compliant.<br>Supporting content:<br><br>New Analytical Quality by Design (AQbD) guidance for selected monographs ensures patient safety by providing an outline of best practices to ensure product quality is upheld throughout the product’s lifecycle.<br>The Advanced Therapy Medicinal Products (ATMP) Flow Cytometry and Vector Copy Number best practice guidance texts offer a practical and phase appropriate validation tool to help your cell therapy programme succeed.<br>A new Supplementary Chapter for Inactivated Veterinary Autogenous Vaccines.<br>Online tools and guides: <br><br>Revision History allows website users to easily view and understand the reasons a change to a monograph has been made.<br>Tracked Changes makes it easier for you to see where we have made changes, so you can only the most recent and relevant monographs.<br>Concise ’How to use the BP’ guide helps you become more familiar with the requirements of the BP, where to locate the different types of information and how to apply a formulated preparation monograph.</p>

<p>Gray, Alistair; Wright, Jane; Goodey, Vincent; Bruce, Lynn<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Alistair Gray - Senior Clinical Pharmacist (Community and Paediatric Services), Jane Wright - Lead Pharmacist, Lancashire Care NHS Trust, Vincent Goodey - Deputy Director of Pharmacy, and Lynn Bruce - Senior Clinical Pharmacist (Medical Assessment Unit)<br><br>ISBN 978 0 85369 787 9<br><br>Published Feb 2011<br><br>Paperback 215 x 130mm (928pp)<br><br><br>DESCRIPTION:<br><br> A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines. Injectable Drugs Guide is an A-Z of approximately 300 injectable drugs in monograph format, each covering the following topics: <br> - pre-treatment checks <br> - dosing regimens <br> - preparation and administration <br> - compatibility and stability information <br> - monitoring requirements during treatment <br> - side effects, interactions and pharmacokinetic information. <br>The Injectable Drugs Guide is designed to support the NPSA risk assessment process and each drug has a risk rating.<br>The book provides a holistic approach to injectable medicines to meet the needs of the many disciplines involved in the clinical use of injectables, and also those providing advice about injectable drug use.<br> Injectable Drugs Guide is also available as an eBook.<br> <br>CONTENTS:<br><br> Preface<br> How to use the Injectable Drugs Guide monographs<br> Injectable Drugs Guide on Medicines Complete<br> Feedback<br> About the authors<br> Contributors<br> Acknowledgements<br> Abbreviations<br> Monographs A - Z<br> Appendix 1. The basics of injectable therapy<br> Appendix 2. Good management principles<br> Appendix 3. Usual responsibilities of individual practitioners<br> Appendix 4. Advantages and disadvantages to parenteral therapy<br> Appendix 5. Injection techniques and routes<br> Appendix 6. Extravasation<br> Appendix 7. Intravascular devices<br> Appendix 8. Infusion devices<br> Appendix 9. Syringe drivers<br> Appendix 10. Ideal body weight, dosing in patients with renal or hepatic impairment<br> Appendix 11. Risk ratings<br> Index of cross-referenced terms<br> <br>REVIEWS:<br><br> May-2011, Doody's Notes<br> "...the book is a quick guide to the use, admixture, administration, monitoring, storage, physical characteristics, and other clinical information for injectable medications. The tables are well organized and the information is easy to retrieve and follow...This is a quick and dirty, go-to book for information on the use of injectable medications. It is a handy, "just in case" reference (just in case you don't know how to mix or administer, or are unsure of the compatibility of a medication). This is a good reference."<br> Judith Klevan, BA biology, BS Pharmacy (Jeanes Hospital), Doody's Notes, May 2011<br> <br> </p>

<p>Midcalf, Brian; Phillips, Mitchell; Neiger, John S; Coles, Tim J<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Edited by Brian Midcalf - Assistant PTQA Course Director, School of Continuing Education, University of Leeds, Mitchell Phillips - West Midlands Quality Assurance Pharmacist, John S Neiger - Chairman, Envair Limited, Haslingden and Tim J Coles - Isolator Specialist, GRC Consultants, Alton<br><br>ISBN 978 0 85369 573 8<br><br>Published May 2004<br><br>Paperback 234 x 156mm (288pp)<br><br><br>DESCRIPTION:<br><br> Pharmaceutical Isolators is an indispensable guide to the design, construction, commissioning, maintenance, use and monitoring of pharmaceutical isolators. The current validation protocols are explained and the book includes some useful technical appendices. <br>Written through the combined technical expertise of the Isolator Working Party, this new title will assist both experienced and new users to understand and manage this technology. The book will also be a useful reference source for auditors, inspectors and all those involved in standard setting and monitoring. <br>CONTENTS:<br><br> 1. Isolator Applications<br> 2. Design<br> 3. Transfer Devices<br> 4. Access Devices<br> 5. Siting of Isolators and Clothing Regimes<br> 6. Cleaning, Decontamination &amp; Disinfection<br> 7. Physical Monitoring<br> 8. Leak Testing<br> 9. Microbiological Monitoring<br> 10. Validation<br> 11. Standards and Guidelines<br> 12. Definiton of Terms<br> A1. 'Handling Cytotoxic Drugs in Isolators in NHS Pharmacies.' HSE/MCA Guidance<br> A2. Training<br> A3. Stainless Steel for Isolators<br> A4. HEPA Filtration Mechanisms, MPPS and Typical Particle Sizes<br> A5. Calculations to Estimate the Size of a Leak That Can Be Detected Using DOP<br> A6. Activated Carbon Filters<br> A7. Useful Tables<br> <br>REVIEWS:<br><br> 01-Mar-05, Drug Development and Industrial Pharmacy <br>'The text is written in a clear and concise manner and desired information is readily accessible.' <br> Linda Felton, University of Mexico, College of Pharmacy, Mexico <br> </p>

<p>Chambers Fox, Shelley<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Shelley Chambers Fox - Clinical Associate Professor, Department of Pharmaceutical Sciences, Washington State University.<br><br>ISBN 978 0 85711 070 1<br><br>Published Jun 2014<br><br>Paperback 234 x 156mm (560pp)<br><br><br>DESCRIPTION:<br><br> Remington Education: Pharmaceutics provides comprehensive yet concise coverage of all aspects of pharmaceutics. The first part of the book covers physico-chemical principles and highlights the importance of designing dosage forms that contain the appropriate dose, are stable, palatable, easily used by the patient and release drugs in a predictable fashion for absorption. The second part applies these formulation principles to the design of dosage forms used by each route of administration. <br>Each chapter advises on both the science of the delivery mechanism and appropriate use of that delivery system including patient counselling points. Each chapter features: <br> - Learning objectives <br> - Key points boxes <br> - Drug examples<br> - Illustrations<br> - Assessment questions<br> - Further reading and references<br>Shelley Chambers Fox is a registered pharmacist with experience in pharmacy practice as well as academia. Written for students who aspire to be practicing pharmacists the author has included numerous case studies and self assessment questions to enable the key concepts to be grasped more readily, while illustrating how the science can be applied to practice to make sure that drugs offer the intended benefit to the patient. <br>Read our interview with the author . <br>Remington Education: Pharmaceutics is also available as an eBook . <br>CONTENTS:<br><br>1. Introduction to dosage form design <br>2. Intermolecular forces and the physical and pharmaceutical properties of drugs <br>3. Dispersed systems <br>4. Properties of solutions and manipulation of solubility <br>5. Chemical stability of drugs <br>6. Drug travel from dosage form to receptor <br>7. Bioavailability, bioequivalence and the Biopharmaceutical Classification System <br>8. Parenteral drug delivery <br>9. Delivery of biopharmaceuticals and the use of novel carrier systems <br>10. Drug delivery to the eye <br>11. Drug delivery from the oral cavity <br>12. Oral delivery of immediate release dosage forms <br>13. Oral delivery of modified release solid dosage forms <br>14. Rectal and vaginal drug delivery <br>15. Nasal drug delivery <br>16. Drug delivery to the lung and from the lung <br>17. Drug delivery to the skin <br>18. Transdermal dosage forms: drug delivery to the blood stream <br>Appendix <br>Answers to questions and cases <br><br>REVIEWS:<br><br> Doody's Reviews, November 2014 <br>"Many chapters include patient counselling tips, which should be helpful for students. Providing examples of marketed products based on the delivery technology discussed in the chapter makes the concept interesting and relevant... <br>...The fundamental theoretical and practical aspects of various drug delivery systems that this book presents will help students develop a solid understanding of the subject." <br> Rahmat M. Talukder, PhD, RPh, Doody's Reviews, November 2014. <br> </p>

<p>Medicines and Healthcare products Regulatory Agency<br><br>Scheduled closure of pharmpress.com<br><br>Compiled by the Inspection and Standards Division, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK<br><br>Product code MC_ORANGE<br><br><br>DESCRIPTION:<br><br> Since its first publication in 1971, the MHRA Orange Guide has been an essential reference for all involved in the manufacture or distribution of medicines in Europe. <br>In one convenient and authoritative source, the MHRA Orange Guide brings together all the main European and UK directives, regulations and legislation relating to the manufacture and distribution of medicines.<br>Compiled by the Inspection, Enforcement and Standards Division, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK.<br> <br> <br> <br> <br> <br> </p>

<p>Mulder, Gerard J; Dencker, Lennart<br><br>First edition<br><br>Scheduled closure of pharmpress.com<br><br>Edited by Gerard J Mulder - Director of Research and Lennart Dencker - Professor and Chairman of Toxicology; Dean, Faculty of Pharmacy at Uppsala University<br><br>ISBN 978 0 85369 593 6<br><br>Published Jun 2006<br><br>Paperback 234 x 156mm (280pp)<br><br><br>DESCRIPTION:<br><br> Pharmaceutical Toxicology explains the methodology and requirements of pre-clinical safety assessments of new medicines. With the focus on medicinal drugs, the most important safety issues of drugs are covered. This includes registration requirements of new drugs and pharmacovigilance. After a general introduction and a number of chapters on basic toxicological principles, organ toxicity of drugs is illustrated by chapters on toxicity in the liver, in the kidney, in the respiratory system and in the immune system. This book combines a broad treatment of the issues relevant for assessing the safety/efficacy balance of a new drug with information on the toxicological knowledge base and methodology. <br>Toxicology studies are carried out on all drug substances to ensure safety. This is an introductory text for students at BSc, MSc and PhD levels, and will be an excellent companion to pharmacology textbooks. <br> <br>CONTENTS:<br><br> 1. General Toxicology<br> 2. Drug Metabolism: Inactivation and Bioactivation of Xenobioptics<br> 3. Molecular and Cellular Mechanisms of Toxicity<br> 4. Teratology<br> 5. Genotoxicity<br> 6. Carcinogenicity of Drugs<br> 7. Liver Toxicity<br> 8. Kidney Toxicity<br> 9. Toxicology in the Respiratory System<br> 10. Immunotoxicity<br> 11. Clinical Toxicology<br> 12. Safety Assessment of Pharmaceuticals: Regulatory Aspects<br> 13. Pharmacovigilance<br> <br>REVIEWS:<br><br> 01-Jun-07, Summer 2007 Issue of the British Toxicology Society Newsletter <br>'...this is a great little book...the text is aimed primarily at new PHD students in the pharmaceutical and related sciences but could equally well serve taught postgraduate students on toxicology, clinical pharmacology, drug development and safety or similar courses. The book 'does exactly what it says on the tin' and will definitely whet the appetite of enthusiastic young researched for toxicology.' <br> Heather M Wallace, Summer 2007 issue of the British Toxicology Society Newsletter <br> 01-Nov-06, Irish Pharmacy Journal <br>'The text is well written, concise and easy to understand with informative and helpful illustrations, figures and tables...it serves as an excellent companion to pharmacology textbooks, dealing with the issues relevant for assessing the safety of new drugs...a good starting point for the novice toxicologist, ambitious undergraduate student or graduate students working in the pharmaceutical sciences.' <br> Irish Pharmacy Journal, November 2006, p418 <br> </p>

<p>Randall, Michael D and Neil, Karen E.<br><br>Third edition<br><br>Scheduled closure of pharmpress.com<br><br>Michael D Randall - Professor of Pharmacology, University of Nottingham Medical School, Nottingham, UK; and Karen E Neil - Pharmacist, Nottingham, UK.<br><br>ISBN 978 0 85711 209 5<br><br>Published Jul 2016<br><br>Paperback 246 x 189mm (496pp)<br><br><br>DESCRIPTION:<br><br> Disease Management provides a comprehensive discussion on the management of diseases which are commonly encountered by pharmacists. Viewing the subject of pharmacology from a clinical perspective, the book takes an inclusive approach to patient care, covers lifestyle issues, and the treatment and use of alternative remedies and complementary medicine. <br>This new edition takes into account the latest changes in clinical guidelines and a new chapter on drug choice and prescribing, including considerations that need to be taken into account. <br>The textbook considers diseases by system, covering common therapeutic issues. Each section includes: <br> - Disease characteristics<br> - Clinical features<br> - Pharmacology of therapeutics used to manage the condition<br> - Treatment guidelines<br> - Concurrent disease<br> - Interactions<br> - Counselling of the patient.<br>Boasting numerous case studies, self-assessment sections and practice points, Disease Management is an invaluable book for pharmacy undergraduates, pre-registration students, practising pharmacists as well as other healthcare professionals. <br> <br>CONTENTS:<br><br>Part A The patient <br>1 Signs and symptoms <br>2 Clinical laboratory tests <br>3 Lifestyle <br>4 Herbal medicine and alternative remedies <br>Part B Treatment <br>5 Drug Choice and prescribing <br>6 Adverse drug reactions and interactions <br>7 Clinical pharmacokinetics <br>Part C Gastrointestinal diseases <br>8 Dyspepsia and peptic ulcer disease <br>9 Nausea and vomiting <br>10 Lower gastrointestinal problems <br>11 The liver patient <br>Part D Cardiovascular diseases <br>12 Hypertension <br>13 Lipids and cardiovascular risk <br>14 Obesity <br>15 Ischaemic heart disease <br>16 Heart failure <br>17 Thromboembolic prophylaxis <br>18 Anaemias <br>19 The renal patient <br>Part E Respiratory diseases <br>20 Coughs and colds <br>21 Allergy <br>22 Respiratory diseases: asthma and chronic obstructive pulmonary disease <br>Part F Central nervous system disorders <br>23 Migraine <br>24 Epilepsy <br>25 Affective disorders <br>26 Anxiety disorders <br>27 Insomnia <br>28 Schizophrenia <br>29 Parkinson’s disease <br>Part G Pain <br>30 Pain management <br>31 Musculoskeletal pain <br>Part H Cancer <br>32 The cancer patient and chemotherapy <br>33 The cancer patient and palliative care <br>Part I Infections <br>34 Bacterial infections <br>35 Non-bacterial infections <br>Part J Dermatology <br>36 Dermatology <br>Part K Endocrine disorders <br>37 Diabetes mellitus <br>38 Thyroid disorders <br>Feedback on self-assessments <br>Appendices <br>1 Formulary of some important classes of drugs, commonly used examples, mechanisms of action and uses <br>2 Some important clinical measurements and therapeutic drug monitoring <br> <br>REVIEWS:<br><br> The Pharmaceutical Journal, October 2016 <br>"A useful book for students and preregistration trainees... <br>...Common diseases — such as diabetes, hypertension, asthma, depression and peptic ulceration — are described, followed by brief summaries of the pharmacology of the drugs used to manage these conditions. There is a strong focus on drug choice so that the reader can appreciate the rationale behind logical prescribing... <br>...drug interactions represent an important therapeutic challenge and attempts have been made to highlight important examples and how they may be overcome... <br>...The book will be of greatest value to pharmacy students in the latter part of their courses and to preregistration graduates undertaking their clinical practice." <br> Laurence A. Goldberg, The Pharmaceutical Journal, 12 October 2016 <br> <br> From the reviews of the previous edition <br>"...it is crucial to maintain your knowledge of pharmacology throughout the pre-registration year and beyond. Knowing your muscarinic receptor from your adrenoceptor will prove hugely beneficial as you prepare for the registration assessment as you won’t need to memorise endless lists of interactions... <br>...the authors do not provide overwhelming detail, but offer the clinical reasoning behind interactions and potential consequences for the patient. The chapter concludes with some punchy practice points which help consolidate the readers learning... <br>...certainly a worthy investment for the pre-registration trainee. It bridges the gap between core scientific principles and clinical practice with ease." <br> Daniel Greenwood, Pharmacist and PhD candidate, University of Manchester, BPSA Graduate Link, Autumn 2015<br> <br>"This is a worthy training tool for pharmacy students to apply what they've learned in the classroom to practical situations for management of patients. This is a nice supplement, it is easy to follow and has appropriate references to support the information outlined in the book" <br> Barbara Lane Giacomelli, PharmD, MBA, BS, Doody's Notes, 5 April 2009<br> <br>"Excellent book to introduce applied pharmacotherapy concepts. Very well written and very simplified. Not all disease states included but great place to start." <br>Five stars. <br> Amazon.com <br> </p>

<p>David H Reissner and Christopher A Langley<br><br>Twelfth Edition<br><br>Scheduled closure of pharmpress.com<br><br>ISBN 978 0 85711 420 4<br><br>Published Jul 2021<br><br>Paperback 234 x 156mm (600pp)<br><br><br>DESCRIPTION:<br><br> The new 12th edition of Dale and Appelbe’s Pharmacy and Medicines Law is your definitive guide to law for pharmacy practice in Great Britain. It covers law and professional regulation and is firmly established as the definitive reference work and student textbook on this subject in Great Britain. This edition has been extensively restructured and revised to include all the most recent changes to pharmacy laws and regulation. Updates include: Revised and restructured new edition of a highly successful text New chapters: introduction to the law, criminal and civil liability, medical devices, lawfully conducting a retail pharmacy business, confidentiality, data protection, and more Greater prominence to professional regulation and NHS chapters Over 50 additional cases than in previous editions to illustrate application of law Dale and Appelbe's Pharmacy and Medicines Law is an invaluable essential resource for pharmacy professionals and students who need access to current information on British law relating to medicines, poisons and the practice of pharmacy. About the Editors David H Reissner, is a solicitor who has spent more than 40 years specialising in pharmacy law. He is a Deputy District Judge and Chair of the Pharmacy Law &amp; Ethics Association. Christopher A Langley is Professor of Pharmacy Law and Practice and Head of Aston Pharmacy School at Aston University, Birmingham, UK. Dale and Appelbe's Pharmacy and Medicines Law Webinar Register to watch the webinar to hear the editors, David Reissner and Christopher Langley discuss what's new in the forthcoming edition, post-Brexit changes in legislation and COVID-19. <br>CONTENTS:<br><br> <br> Foreword <br> <br> About the contributors <br> <br> Introduction <br> <br> Legislation <br> <br> Cases <br> <br> Abbreviations and acronyms <br> <br> 1 Introduction to the law in Great Britain <br> <br> 2 The regulation of pharmacy and other healthcare professions <br> <br> 3 National Health Service law <br> <br> 4 Human medicines and medical devices: scope of regulations <br> <br> 5 Human medicines: the licensing system <br> <br> 6 Lawfully conducting a retail pharmacy business <br> <br> 7 Medicinal products subject to general sale <br> <br> 8 Human medicines: Pharmacy medicines <br> <br> 9 Human medicines: Prescription Only Medicines <br> <br> 10 Human medicines: exemptions from controls <br> <br> 11 Controlled drugs <br> <br> 12 Veterinary medicines <br> <br> 13 Human medicines: wholesale dealing and brokering <br> <br> 14 Human medicines: sale and supply of homoeopathic medicines <br> <br> 15 Herbal medicinal products <br> <br> 16 Human medicines: labelling, packaging and leaflets <br> <br> 17 Human medicines: advertising <br> <br> 18 Pharmacopoeias and compendia <br> <br> 19 Poisons, denatured alcohols and chemicals <br> <br> 20 Medical devices <br> <br> 21 Confidentiality and data protection <br> <br> 22 Professional conduct <br> <br> 23 Fitness to practise <br> <br> 24 Criminal and civil liability <br> <br> Appendices <br> <br> 1 The Standards for pharmacy professionals <br> <br> 2 Patient Group Directions <br> <br> 3 Schedule 1A to the Poisons Act: Regulated and Reportable Substances <br> <br> </p>

<p>The BP 2024 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023.<br><br> BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br><br>The BP 2024 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2023<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>

<p>KETOBEMIDONE HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>INDINAVIR SULFATE - REFERENCE SPECTRUM</p>

<p>DIPOTASSIUM CLORAZEPATE MONOHYDRATE - REFERENCE SPECTRUM</p>

<p>RILMENIDINE DIHYDROGENOPHOSPHATE - REFERENCE SPECTRUM</p>

<p>PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM</p>

<p>POLYSORBATE 40 - REFERENCE SPECTRUM</p>

<p>TIOCONAZOLE - REFERENCE SPECTRUM</p>